Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids-Reference-Cited by-同舟云学术

Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

Published:2018-01-05 Issue:3 Volume:61 Page:671-680
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Wewer Albrechtsen Nicolai J.,Færch Kristine,Jensen Troels M.,Witte Daniel R.,Pedersen Jens,Mahendran Yuvaraj,Jonsson Anna E.,Galsgaard Katrine D.,Winther-Sørensen Marie,Torekov Signe S.,Lauritzen Torsten,Pedersen Oluf,Knop Filip K.,Hansen Torben,Jørgensen Marit E.,Vistisen Dorte,Holst Jens J.

Funder

European Foundation for the Study of Diabetes

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s00125-017-4535-5/fulltext.html

Reference49 articles.

1. Gromada J, Franklin I, Wollheim CB (2007) α-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28:84–116

2. Kazda CM, Garhyan P, Kelly RP et al (2015) A randomized, double-blind, placebo-controlled phase 2 study of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes. Diabetes Care 37:1241–1249

3. Petersen KF, Sullivan JT (2001) Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia 44:2018–2024

4. Johnson DG, Goebel CU, Hruby VJ, Bregman MD, Trivedi D (1982) Hyperglycemia of diabetic rats decreased by a glucagon receptor antagonist. Science 215:1115–1116

5. Boden G, Rezvani I, Owen OE (1984) Effects of glucagon on plasma amino acids. J Clin Investig 73:785–793

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-10-01

2. Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes;Diabetologia;2024-08-13

3. Lipid Metabolism in MASLD and MASH: from mechanism to the clinic;JHEP Reports;2024-08

4. Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes;Frontiers in Endocrinology;2024-07-04

5. Impairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitus;Diabetes, Obesity and Metabolism;2024-07-03